Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database-Reference-Cited by-同舟云学术

Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

Published:1999-10 Issue:1 Volume:107 Page:154-161
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Dhedin ,Giraudier ,Gaulard ,Esperou ,Ifrah ,Michallet ,Milpied ,Rio ,Cahn ,Molina ,Laporte ,Guilhot ,Kuentz ,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1999.01666.x/fullpdf

Reference42 articles.

1. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

2. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma

3. Commentary and Opinion: I. Principal Component Analysis, Variance Partitioning, and “Functional Connectivity”

4. 4 F. Cabanillas, S. Jannagath, and T. Philip (1990 ) Management of recurrent or refractory disease.The Non-Hodgkin's Lymphomas(ed. by I. Magrath), pp. 359, 371 . Edward Arnold, London.

5. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20+ B Cell Malignancies;Biology of Blood and Marrow Transplantation;2020-10

2. Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease;Bone Marrow Transplantation;2018-11-09

3. Hematopoietic Cell Transplantation for Richter Syndrome;Biology of Blood and Marrow Transplantation;2016-11

4. Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party;Bone Marrow Transplantation;2015-11-30

5. Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies;Bone Marrow Transplantation;2015-08-03